Profiling the RNA levels of cancer-related genes in the analysed FMCs. by Daniela Ferreira (173362)

“…Each quantification graphic also presents the percentage of tumours with increase (≥2-folds), maintenance (between 0.5 and 2-folds) or decrease (≤0.5-folds) RNA levels of each gene. …”

Erratum: Why Do the Clients of Georgian Needle Exchange Programmes Inject Buprenorphine? by Otiashvili D. (4271656)

“…<i>Results:</i> Pharmaceutical buprenorphine in the form of Subutex® was the most commonly injected drug in terms of lifetime (95.5%) and last-month (75%) prevalence of use. 48% of those study participants who had injected Subutex at some point reported having used it to cope with withdrawal or to give up other opioids. 90.5% of Subutex injectors used 1–2 mg as a single dose, and the mean frequency of its injection was 6 times per month. 75% of Subutex injectors had used 3 or more types of illegal drugs during the last 30 days. …”

Placental genes with considerable expressional change in progression from early to mid-pregnancy. by Liis Uusküla (121629)

“…Color intensity reflects mean log2 fold change in gene expression with one first trimester sample (week 5; 38 gestational days) as reference. …”

Overall influence of the levels of stimulation on behavioral thresholds and latencies. by Jean-Michel Benoist (270919)

“…On average, the behavioral threshold Tβ was 44.9 (44.5–45.3)°C with a significant tendency to decrease from the proximal to the distal parts of the tail, best described by the equation Tβ = 47.4−0.014 D (F_44,1 = 12.2; p<0.01). …”

Reduced willingness to participate in large events. by Alyssa H. Sinclair (17102689)

“…Change in willingness was rated on a 5-point Likert-style scale. A) Mean change in willingness by event size. …”

Supplemental Figure 10 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity by Dong Joon Kim (280038)

“…Vehicle, herbacetin (100 mg/kg B.W. p.o. or 2 mg/kg B.W. i.p.) or DFMO (1 g/kg B.W. p.o.) was administered by gavage or intraperitoneal injection 5 times per week for 5 weeks. (A) DFMO significantly decreased hearing (measured as prepulse inhibition or PPI) on day 35. …”

Normalized fluorescence of calcium indicator Fluo-4 with and without addition of calcium chelator EGTA. by Stefan Kalies (388164)

“…The mean and standard error of three experiments with five irradiated and analyzed cells are shown.…”

Impact of hemodialysis session on handgrip strength by Ana Paula Pinto (10467189)

“…Methods: This is a cross-sectional study with 156 patients [57.7% male, median age of 56.5 (42-67) years old, 28.8% diabetes, mean BMI of 24.75 ± 4.5 kg/m2 and HD vintage of 38 (19.25 to 72.75) months]. …”

Kupffer cell populations. by Ivan Linares (5059373)

“…Abbreviations: RGZ-Rosiglitazone, CTRL-Control. Five experiments (n = 5) per group per time point were performed. …”

Impact of local reference laboratory and external quality assurance measures on BUD control. by Marcus Beissner (139059)

“…Analysis for linear trends in proportions revealed a significant (<i>p</i><0.01) increase of patients presenting with non-ulcerative lesions from 37.0% (2007–2010) to 50.0% (2011–2012). The mean duration of disease among patients with non-ulcerative lesions before presentation and establishment of clinical diagnosis decreased not significantly from 51.8 (95% CI: 19.0–84.7) to 35.0 (95% CI: 23.5–46.5) days during the two observation periods. …”

FACS Analysis of TEC profile and quantification of TEC numbers in response to DKK1 mediated inhibition of Wnt signaling. by Masako Osada (253586)

“…Means represent the total cell number/thymus, calculated from 3 independent experiments utilizing 5-pooled dissociated thymi from each strain. …”

Behavioural results, expressed as difference between probe trials and preceding reinforced trials. by Hannah Kurtenbach (14237769)

“…<p>Results are shown both for the mean across all five probe blocks (left) and separately for each probe block. …”

Evolution of DDM parameters with plasticity. by Jyotika Bahuguna (729510)

“…The mean over all networks is shown by large black circles. …”

Safety and Feasibility of Long-term Intravenous Sodium Nitrite Infusion in Healthy Volunteers by Ryszard M. Pluta (233325)

“…Toxicity included a transient asymptomatic decrease of mean arterial blood pressure (more than 15 mmHg) and/or an asymptomatic increase of methemoglobin level above 5%. …”

ELISA quantification of soluble and insoluble Aβ in frontal and temporal lobes. by Alex E. Roher (164249)

“…Frontal (<b>G</b>) and temporal (<b>H</b>) cortices GDFA/GHCl-soluble Aβ₄₂. There was a mean decrease in Bapi-AD Aβ₄₂ relative to NI-AD more noticeable in the latter than in the former. …”

Image1_Effectiveness of medication self-management, self-monitoring and a lifestyle intervention on hypertension in poorly controlled patients: The MEDICHY randomized trial.tif by Fabián Unda Villafuerte (18589192)

“…The primary outcome was decrease in the mean SBP at 6 months relative to baseline.…”

Table_1_Sex-related differences in self-reported treatment burden in patients with atrial fibrillation.DOCX by Miroslav Mihajlovic (14055435)

“…</p>Results<p>Of 331 patients (mean age 65.4 ± 10.3 years, mean total AF history 6.41 ± 6.62 years), 127 (38.4%) were females. …”

Neuroprotection by CPE-ΔN is mediated by FGF2. by Xiao-Yan Qin (666512)

“…Data are normalized against 18S RNA and presented as a % compared to control (LacZ) cells. Values are the mean ± SEM (n = 5), <i>t</i> test, ** p<0.01. At least three independent experiments were done. …”

AR-mediated transcriptional regulation of apoptotic genes in HPr-1AR. by Congcong Chen (796149)

“…The 2-fold cutoff boundaries (orange lines) and 1.5-fold cutoff boundaries (gray lines) were determined from the mean change in expression level for DHT- versus CTL-treated cells. …”

HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial by Anita Y.M. Kwan (11868016)

“…</p> <p><b>Conclusions:</b> Dulaglutide 1.5 mg treatment was statistically associated with a long-lasting decrease in HbA1c over 72 months, irrespective of baseline duration of diabetes, microvascular disease, and BMI.…”